As shown in Figure 3(a), the IL-1β concentrations in the serum of patients with CAD were significantly increased compared to control subjects (mean ± SD = 2.177 ± 1.921 versus 1.668 ± 1.319 pg/mL) (P = 0.017). This evidence concerns the gene IL1B and coronary artery disorder.